Worldwide Clinical Trials

Evelyn Graham has been appointed executive vice president of Global Business Development for Worldwide Clinical Trials, Inc. Ms. Graham will lead sales, marketing and business development strategies for the late stage business.

“Evelyn’s proven experience in drug development and knowledge of the industry will be a tremendous asset to Worldwide Clinical Trials and our clients,” said Angelico Carta, M.D., president of Worldwide Clinical Trials. “She has extensive experience in clinical development, corporate strategy and business development, and this will be invaluable.”

Ms. Graham has more than 20 years of drug development experience and previously served as chief executive officer and director of TorreyPines Therapeutics, Inc., where she led the company’s merger with Raptor Pharmaceuticals Corp. in September 2009. Ms. Graham joined TorreyPines in 2004 as vice president, development, and became vice president, corporate development, in 2005.